REPLY, ESPRIT, KORA and FACIL1 pacemakers 에 대한 현장 안전성 서한
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI)에 따르면, 해당 현장 안전성 서한 는
Slovenia
에서 LivaNova PLC 에 의해 제조된 제품과 관련되어 있습니다.
이것은 무엇인가요?
현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.
Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
데이터 추가 비고
원인
This letter provides information about a new software version that improves the accuracy of the
estimated residual longevity calculated and displayed by the programmer during a follow-up
exam of patients implanted with livanova pacemakers.
the overall longevity of these devices is not affected.
when an implanted device approaches the recommended replacement time (rrt), the
previous, less accurate, residual longevity estimate provided by the programmer at follow-up
could result in reaching rrt between two follow-up visits. no permanent injury or death has
occurred as a result of this inaccuracy. .